Results 41 to 50 of about 99,805 (324)

Prevalence, association, and prognostic significance of polypharmacy and sarcopenia in patients with liver cirrhosis

JGH Open, 2023
Background and Aim Polypharmacy and sarcopenia are increasing public health problems worldwide. However, data on the prevalence, association, and prognostic significance of polypharmacy and sarcopenia in patients with liver cirrhosis are limited. Methods
Tatsunori Hanai, Kayoko Nishimura, Takao Miwa, Toshihide Maeda, Kenji Imai, Atsushi Suetsugu, Koji Takai, Masahito Shimizu   +7 more
doaj   +1 more source

Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy [PDF]

, 2016
Myotonic dystrophy (DM) and facioscapulohumeral muscular dystrophy (FSHD) are the two most common adult muscular dystrophies and have progressive and often disabling manifestations.
Conn, Kelly, Fitzgerald, Bryan, Hilbert, James E., Luebbe, Elizabeth A., Moxley, Richard T., III, Parkhill, Amy L., Smith, Joanne, Walker, Andrew   +7 more
core   +2 more sources

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Prevalence and determinants of polypharmacy in cardiovascular patients attending outpatient clinic in Ethiopia University Hospital.

PLoS ONE, 2020
BACKGROUND:While there are advances in medicine and pharmaceutical care, the burden of medication use has also grown with polypharmacy. In this regard, cardiovascular patients are subjected to polypharmacy for a longer period. OBJECTIVE:The present study
Yonas Getaye Tefera, Mekuriaw Alemayehu, Gashaw Binega Mekonnen   +2 more
doaj   +1 more source

A Cross-Sectional Study Comparing the Frequency of Drug Interactions After Adding Simeprevir- or Sofosbuvir-Containing Therapy to Medication Profiles of Hepatitis C Monoinfected Patients. [PDF]

, 2015
INTRODUCTION:This study compares the expected occurrence of contraindicated drug-drug interactions (XDDIs) when simeprevir (SIM)- or sofosbuvir (SOF)-containing therapy is added to medication profiles of patients with hepatitis C (HCV) monoinfection to ...
Bliss, Steven, Davis, Melissa, Koroglu, Arden, McNutt, Louise-Anne, Miller, Christopher, Nasiri, Mona, Patel, Nimish   +6 more
core   +1 more source

Variation of polypharmacy in older primary care attenders occurs at prescriber level

BMC Geriatrics, 2018
Background Polypharmacy is particularly important in older persons as they are more likely to experience adverse events compared to the rest of the population.
Su Miin Ong, Yvonne Mei Fong Lim, Sheamini Sivasampu, Ee Ming Khoo   +3 more
doaj   +1 more source

Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe the use of central stimulants and amantadine for fatigue in MS and evaluate a potential association with reduced work loss in people with MS. Methods We conducted a nationwide, matched, register‐based cohort study in Sweden (2006 to 2023) using national registers with prospective data collection.
Simon Englund, Johan Reutfors, Thomas Frisell, Fredrik Piehl   +3 more
wiley   +1 more source

Defining pediatric polypharmacy: A scoping review.

PLoS ONE, 2018
ObjectivesLack of consensus regarding the semantics and definitions of pediatric polypharmacy challenges researchers and clinicians alike. We conducted a scoping review to describe definitions and terminology of pediatric polypharmacy.MethodsMedline ...
Paul M Bakaki, Alexis Horace, Neal Dawson, Almut Winterstein, Jennifer Waldron, Jennifer Staley, Elia M Pestana Knight, Sharon B Meropol, Rujia Liu, Hannah Johnson, Negar Golchin, James A Feinstein, Shari D Bolen, Lawrence C Kleinman   +13 more
doaj   +1 more source

Survey of polypharmacy prescription in a tertiary care Hospital, Belagavi

Kanem Journal of Medical Sciences, 2021
Background: Polypharmacy is the use of four or more medications in one prescription or implies the prescription of too many medications for an individual. Concerns about polypharmacy include increase adverse drug reactions, drug interactions, prescribing
Suma Sukumaran, Premkumar Sundararajan, Hari Prasad Vishwanathan, Abeetha Saisubramanian, Tejashwini K, Renu Sharda, Hemachandrika Chidambaram   +6 more
doaj   +1 more source

Polypharmacy and risk of dementia progression in older adults with mild cognitive impairment: A longitudinal cohort study. [PDF]

Alzheimers Dement (N Y)
Hsu YH, Liang CK, Chou MY, Shen HC, Wang YC, Iwaki H, Lin YT, Fann YC.   +7 more
europepmc   +3 more sources